and ingredients.

Poietis is currently developing 3D physiological models and has partnerships with major pharmaceutical and cosmetic groups. These tissue models allow for a more predictive in vitro assessment of the toxicity and the efficacy of candidate drugs and new cosmetic ingredients.

Poietis has undertaken several projects with international leaders to develop complex bio-printed products such as the bioprinting of a hair follicle with L'Oréal (see Press Release). Poietis has developed its single-cell bioprinting platform to make tissue bioprinting processes compatible with the requirements of industrial production and the standards for manufacturing clinical products.